Johnson & Johnson acquires Abiomed for $16.6 billion.
On 22 December 2022, Johnson & Johnson, the multinational healthcare company, announced that it had completed its $16.6 billion acquisition of Abiomed, the medical device technology company engaged in the research, development and
Read more...